Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines N. Aliabadi, J.E. Tate, U.D. Parashar Clinical.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines N. Aliabadi, J.E. Tate, U.D. Parashar Clinical.

Vaccines for the elderly

Probable aerosol transmission of severe fever with thrombocytopenia syndrome virus in southeastern China Z. Gong, S. Gu, Y. Zhang, J. Sun, X. Wu, F.

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

Cryptococcosis—the impact of delay to diagnosis

Universal influenza vaccines: a realistic option?

Next-generation sequencing technologies and their application to the study and control of bacterial infections J. Besser, H.A. Carleton, P. Gerner-Smidt,

J. Moran-Gilad, E. Kaliner, M. Gdalevich, I. Grotto

Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years:

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines N. Aliabadi, J.E. Tate, U.D. Parashar Clinical.

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

D. Holt, F. Bouder, C. Elemuwa, G. Gaedicke, A. Khamesipour, B

Approach to diagnosis of infective endocarditis

Varicella vaccination: a laboured take-off

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Migrant health—a cause for concern?

Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era T.I. Pedersen, M. Howitz, C. Østergaard Clinical.

Images in CMI Clinical Microbiology and Infection

Serological surveillance for Penicillium marneffei infection in HIV-infected patients during 2004–2011 in Guangzhou, China Y.-F. Wang, H.-F. Xu, Z.-G.

Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals G. Ippolito Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient P. Helbling Clinical Microbiology.

Refugee crisis and re-emergence of forgotten infections in Europe

D. Holt, F. Bouder, C. Elemuwa, G. Gaedicke, A. Khamesipour, B

Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children N. Agrinier, M. Le Maréchal,

R. Cantón Clinical Microbiology and Infection

Probable aerosol transmission of severe fever with thrombocytopenia syndrome virus in southeastern China Z. Gong, S. Gu, Y. Zhang, J. Sun, X. Wu, F.

Louis Pasteur, from crystals of life to vaccination

Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years:

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Surveillance of Legionnaires’ disease in Austria

First isolation of Akkermansia muciniphila in a blood-culture sample

Hepatitis C: global epidemiology and strategies for control

Immunogenicity and safety of the 13-valent Pneumococcal Conjugate vaccine in 23- valent pneumococcal polysaccharide vaccine-naive and pre-immunized patients.

Towards the risk of yellow fever transmission in Europe

P.L. Lopalco, P. Carrillo Santisteve

Enhanced surveillance of carbapenemase-producing Gram-negative bacteria to support national and international prevention and control efforts R. Freeman

Rotavirus vaccination: a concise review

Human metapneumovirus infection among children in Taiwan: a comparison of clinical manifestations with other virus-associated respiratory tract infections

Isospora belli Clinical Microbiology and Infection

Epidemiology of opportunistic infections in AIDS patients

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Can we control all-cause meningococcal disease in Europe?

Elements of design: the knowledge on which we build

R. Bitterman, M. Paul, D. Polak, Y. Geffen

Previously unknown species of Aspergillus

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

Symposia and Oral Presentations

Sexually acquired Zika virus: a systematic review

Systematic review of antibiotic consumption in acute care hospitals

Abstracts cont. Clinical Microbiology and Infection

Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection E. Knops, E. Heger Clinical Microbiology.

Vaccinations against respiratory tract infections at Hajj

C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D

S. M. Bartsch, J. A. McKinnell, L. E. Mueller, L. G. Miller, S. K

A. van Samkar, M. C. Brouwer, Y. Pannekoek, A. van der Ende, D

The atypical pneumonias: clinical diagnosis and importance

Virology: a scientific discipline facing new challenges

R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L

J.L. Balcázar Clinical Microbiology and Infection

CMI editorial report, 2016 Clinical Microbiology and Infection

Molecular history of plague

Impact of antibiotic restrictions: the patient's perspective

The burden of chikungunya in the Pacific

CMI readers' survey Clinical Microbiology and Infection

Rajko Saletinger, Mario Poljak, Franc Strle

The future of diagnostic bacteriology

Presentation transcript:

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines N. Aliabadi, J.E. Tate, U.D. Parashar Clinical Microbiology and Infection Volume 22, Pages S128-S135 (December 2016) DOI: 10.1016/j.cmi.2016.03.007 Copyright © 2016 Terms and Conditions

Fig. 1 Rotavirus introduction worldwide, PATH, as of January 2016. Clinical Microbiology and Infection 2016 22, S128-S135DOI: (10.1016/j.cmi.2016.03.007) Copyright © 2016 Terms and Conditions

Fig. 2 Total and positive rotavirus tests, National Respiratory and Enteric Virus Surveillance System data, United States, 2000–2014 [19]. Clinical Microbiology and Infection 2016 22, S128-S135DOI: (10.1016/j.cmi.2016.03.007) Copyright © 2016 Terms and Conditions